Erelzi 25 mg (Etanercept SOLUTION) 25 MG

ERELZI 25 MG is a subcutaneous solution containing etanercept, used for managing inflammatory conditions. This biologic medication helps reduce symptoms and improve quality of life.

Strength

25 MG

Pack Size

0.5ML

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ERELZI 25 MG is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by targeting specific proteins in the body to reduce inflammation. Patients often wonder, 'What is ERELZI used for?' This medication is designed to alleviate pain and swelling associated with these conditions.

Side Effects

Common effects of ERELZI 25 MG may include injection site reactions, such as redness or itching. Some users also report fatigue or mild headaches. These effects are generally mild and temporary, but it's important to monitor any persistent or severe symptoms.

Precautions & Warnings

ERELZI 25 MG should be handled with care, ensuring proper storage and administration techniques. It is crucial to follow healthcare provider instructions for subcutaneous use. Patients with a history of infections or allergies should discuss this with their healthcare provider before starting treatment.

Avoid Interactions

ERELZI 25 MG may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all current medications to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of this medication.

Frequently Asked Questions

ERELZI 25 MG is used to manage inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

ERELZI 25 MG is administered subcutaneously, typically by injection. Follow your healthcare provider's instructions for proper administration.

Common side effects may include injection site reactions, fatigue, and mild headaches. These effects are usually temporary.

ERELZI 25 MG may interact with other medications, especially those affecting the immune system. Consult your healthcare provider for personalized advice.

ERELZI 25 MG should be stored as per the manufacturer's instructions, typically in a refrigerator. Avoid freezing and keep out of direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.